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Abstract 
BACKGROUND: The main components in controlling and treating seizures are antiepileptic drugs (AEDs). Mostly, 
the systemic side effects of these drugs are regarded very important; however, these drugs can also cause serious 
mucocutaneous side effects. Carbamazepine is a drug which is used to treat epilepsy. Side effects of this drug can 
range from skin rash to toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS). The purpose of this 
study was to evaluate skin complications of carbamazepine in children with epilepsy. 
METHODS: This study was performed on 99 children, aged 2 months to 11 years, with the diagnosis of skin 
complications after taking carbamazepine. Records were examined and their initial profiles including their medical 
skin conditions and rashes were recorded within the checklist. Data were entered into SPSS software. Measures of 
central tendency and dispersion were achieved. Finally, the relationship between the drug and the cutaneous 
reactions of these patients was analyzed using the chi-square test. 
RESULTS: The most common complications among the patients were maculopapular lesions and skin 
erythroderma, with the prevalence of 37.4% for each. Other types of skin lesions included papules with 14.1%, 
macules with 8.1%, and SJS with 3.0%. A significant association (P = 0.02) between the types of the skin lesion 
and the dose of carbamazepine was observed; the more the dosage was, the more severe skin lesions were. 
CONCLUSION: The most common cutaneous reactions to carbamazepine were erythroderma and maculopapular rash 
in the patients. The findings of this study also revealed that the lack of drug compliance was of high importance. 
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Introduction1 
Anticonvulsants play the main role in 
controlling and curing seizures. The 
prevalence of seizures in Iran is about 1% and 
various anticonvulsants are used in this 
country. Mostly, the systemic side effects of 
these medications are considered, e.g., 




hepatitis and kidney failure; however, they can 
cause mucocutaneous lesions leading to 
discontinuance or replacement of the 
medicine. Some of the most prevalent 
cutaneous side effects are: exanthema, 
hypersensitivity syndrome, lymphoma-like 
symptoms, erythema multiforme (EM), 
erythroderma, toxic epidermal necrolysis 
(TEN), drug-induced lupus erythematosus 
(DILE), Stevens-Johnson syndrome (SJS), 
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hyperplasia, hypertrichosis, hair loss, and hair 
color changes.1 Among the anticonvulsants, 
aromatic compounds such as phenytoin, 
phenobarbital, and carbamazepine are more 
likely to cause skin lesions which sometimes 
may require hospitalization. The pathogenesis 
of these skin problems looks multifactorial.2,3 
The side effects of anticonvulsants are the 
major cause of morbidity and sometimes 
mortality during the treatment of epilepsy in 
patients, which would probably affect their 
quality of life and burden of disease. The exact 
incidence rate of adverse reactions to these 
drugs is not available due to the outpatient 
treatment for both epilepsy and the adverse 
drug reactions (ADRs) in majority of the cases. 
Most of these side effects are mild and will not 
get the patients hospitalized. In outpatient 
treatment, the side effects are not properly 
reported or recorded; therefore, it is difficult to 
estimate the incidence rate of these complications. 
 Carbamazepine is a common drug used for 
treating epilepsy. The skin reactions range 
from maculopapular eruptions to SJS and 
TEN.1 The drug-induced skin eruptions are 
distinguished  from the non-drug-related 
cases, based on the patient’s history, the 
clinical examination, and the features of the 
eruptions. The purpose of this study was to 
evaluate the cutaneous reactions to 
carbamazepine in epileptic patients who were 
treated with this medicine and were recorded 
in Taleghani Hospital of Gorgan, Iran, in 2012. 
Materials and Methods 
This cross-sectional study was carried out on 
the children who were treated with 
carbamazepine as a medication for epilepsy 
and were hospitalized by virtue of skin lesions 
and had hospital records. The sample size was 
determined 99 cases, based on 80% power and 
95% level of confidence considering the 
missing information in the records. Data in the 
records were extracted based on a checklist 
that included skin problems caused by taking 
medications, drug-induced rashes, basic 
information of the patients, etc. The data were 
encoded and entered into SPSS software 
(version 18, SPSS Inc., Chicago, IL, USA). 
Measures of central tendency and variability 
and the relationship between cutaneous side 
effects of the drug and demographic 
characteristics of these patients were analyzed 
using the chi-square test. 
Results 
During the year 2012, 123 cases were 
hospitalized in Taleghani Hospital due to 
cutaneous lesions which were appeared while 
taking carbamazepine. Of all these patients,  
20 were excluded: 5 for lacking proper 
medication compliance and failure to comply 
with the right drug consumption as written in 
their prescriptions, 3 for incomplete hospital 
records, and 12 for consulting with other 
health services, e.g., allergy and infection units 
and accordingly for the probability of being 
diagnosed with a medical complication other 
than carbamazepine-induced cutaneous 
reactions. Finally in this study, of the 
remaining 103 patients, 99 children aged from 
2 months to 11 years were randomly chosen 
and examined. They were admitted to 
Taleghani University Hospital of Gorgan and 
were diagnosed with carbamazepine-induced 
cutaneous lesions. In terms of age frequency, 
the average age of the hospitalized patients 
that participated in this study was 44.49 
months and the standard deviation (SD) was 
33.22. The minimum age among the patients 
was 2 months and the maximum was 11 years. 
25% were less than 16 months, 25% were 16 to 
37 months, and the other 50% were aged 
between 37 and 67 months.  
According to figure 1, while assessing the 
types of skin reactions caused by 
carbamazepine in patients, we observed that 
the most prevalent reactions were 
erythroderma and mucopapular eruptions 
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most infrequent reaction with the prevalence 
of 3.0%. The prevalence of papules and 
macules was 14.1% and 8.1%, respectively. 
 
 
Figure 1. Absolute frequencies of different types 
of rash in children treated with carbamazepine 
 
In this survey, the number of males who 
were affected with rashes due to using 
carbamazepine was higher. In terms of 
ethnicity, 41 patients (41.4%) were Fars, 18 
patients (18.2%) were Turkmen, 26 patients 
(26.3%) were Sistani, and 14 patients (14.1%) 
were of other ethnic groups. 
Studying the patients, it was found out that 
the majority of them (77.8%) had no history of 
allergic reactions to any foreign matter or 
medicine. Among the types of seizure, 
generalized seizures were more prevalent 
happening to 60 patients (60.6%) and partial 
seizures were less seen with the prevalence of 
39.4%. The relationship between the types of 
skin lesions and the types of seizures are 
compared in table 1. It should be noted that no 
meaningful significant relationship was 
observed between sex and the type of skin 
reaction after the drug use (P = 0.06). 
The average duration of drug use in 
patients was 12.82 ± 6.56 days. The minimum 
and maximum intervals between taking the 
drug and onset of the reactions were 4 days 
and 30 days, respectively. Concerning the 
interval between emergence of skin lesions and 
going to the hospital, the average time was 
3.25 ± 3.07 days; the minimum interval was  
1 day (going on the same day that rashes 
appeared) and the maximum interval was  
5 days. The relationship between types of skin 
lesions and the time each takes to appear is 
evaluated in figure 2. 
 
 
Figure 2. Relationships between types of skin 
lesions and rash start time 
 
In terms of the relation between types of 
skin lesions and the daily drug dosage used by 
the patients, analysis of variance (ANOVA) 
statistical test showed that there was a 
significant correlation here; the more the 
dosage was, the more severe lesions were. 
With regard to the possible influence of 
ethnicity on the occurrence of skin reactions 
during treatment with this medicine, chi-square 
analysis was used to assess this hypothesis.  
 
Table 1. Comparison of relations between types of skin lesions and convulsions among the patients (in 
terms of the number of people) 
Type of seizure Erythroderma Macules Papules Maculopapular SJS P 
Generalized 25 5 6 22  2 0.61 
Partial 12 3 8 15  1 
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Findings indicated that erythroderma and 
maculopapular rash were more prevalent in 
Fars patients and macules were more common 
in Turkmen ones. Statistically, this difference 
was not a significant correlation (P = 0.28) 
(Table 2). 
 
Table 2. Comparison of relation between types 
of skin lesions and the daily drug dosage 
Type of skin 
lesions 
Average (mg/day) SE P 
Erythroderma 237.84 13.75 0.02 
Macules 256.25 22.03 
Papules 321.43 32.61 
Maculopapular 347.57 12.73 
SJS 350.00 76.37 
SJS: Stevens-Johnson syndrome; SE: Standard error 
Discussion 
This study was performed on 99 children aged 
2 months to 11 years who were referred to 
Taleghani Hospital of Gorgan, in 2012, and 
were diagnosed with adverse skin reactions 
after carbamazepine therapy. In terms of age 
frequency, the average age of hospitalized 
patients that participated in this study was 
44.49 ± 33.22 months. 
The minimum age among the patients was  
2 months and the maximum was 11 years. 25% 
were less than 16 months, 25% were 16 to 37 
months, and the other 50% were aged between 
37 and 67 months. Mamishi et al. reported  
7 Iranian children with severe skin reactions 
caused by barbiturates. These children were 
aged 2 to 11 years. Their symptoms began  
1-2 weeks after taking the drug. Early 
prodromal symptoms were fatigue, fever, 
cough, anorexia, and then the mucocutaneous 
manifestations started to appear and worsen 
gradually. The skin reactions ranged from skin 
rashes to large blisters.4 
 In our study, the majority of patients were 
male with the frequency of 61.6%. About 
ethnicities of patients with skin lesions caused 
by carbamazepine, the majority was Fars, and 
after that, the number of Sistani and Turkmen 
patients was respectively higher. In this 
survey, 77.8% of the patients had no specific 
history of allergy to any food or drug and only 
22.2% of them had histories of allergies. 
Comparing the relationships between the 
types of skin lesions and the patients’ allergy 
backgrounds did not indicate any significant 
correlation. Concerning the family relationship 
between parents of the children, 37 children 
had relative parents and the other 62 did not. 
The statistical analysis showed that there was a 
correlation about this in the patients. Assessing 
types of seizure after the initial diagnoses 
indicated that 60.6% of the seizures were 
generalized and the other 39.4% were partial. 
The average time of carbamazepine treatment 
was 12.82 ± 6.56 days among patients. Garcia 
et al. reported a patient with severe 
carbamazepine-induced cutaneous reaction in 
the treatment of post-herpetic neuralgia 
(PHN). The patient was treated with 
carbamazepine and amitriptyline due to 
neuralgia. After 15 days, she developed 
malaise, muscle pain, with a mild non-specific 
cutaneous rash. Carbamazepine was 
discontinued immediately. One week later, she 
was hospitalized with urticaria, generalized 
exanthema, bullae, and maculopapular rashes 
all over her body. She evolved with 
progressive worsening of her symptoms, with 
increase in the number and size of cutaneous 
lesions besides areas of necrosis and loosening 
of the epidermis in different parts of her body. 
Eventually, this worsening evolved to septic 
shock followed by death.5 
The dose of carbamazepine used by patients 
was also assessed. The average recommended 
dosage was 15 to 20 mg per kg of body weight. 
Unfortunately, not every family had effective 
medication compliance and some failed to live 
up to the dosage a neurologist had prescribed 
for them. This resulted in occurrence of 
cutaneous reactions and hospitalization. These 
patients were excluded from this study. The 
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were as follows: 37.4% erythroderma, 37.4% 
maculopapular eruptions, 14.1% papules, 8.1% 
macules, and 3.0% SJS. According to the study 
of Malek Afzali and colleagues, maculopapular 
rash was the onset of symptoms in every 
patient. The incidence rates of erythroderma 
and SJS were 35.5% and 28.9%, respectively. 
19.7% of the patients had TEN, 10.5% of them 
had maculopapular eruptions, and 5.0% had 
both maculopapular eruptions and urticaria. 
Phenytoin was the most common drug causing 
skin reactions. About the onset time of the side 
effects, the minimum time was 10 days and the 
maximum time was 5 years. The skin lesions 
were also assessed in hospitalized patients 
during 5 years. 734 patients showed symptoms 
for six types of skin lesion during this time. 
Three common non-serious lesions were 
urticaria, exanthema, and lesions looking like 
EM; and the rest were common serious 
complications such as SJS rash and exfoliative 
dermatitis. Anticonvulsants were the most 
common drugs causing serious skin reactions. 
Among patients with more serious skin 
reactions, the number of males and the average 
age were higher. They had been using the drug 
for a longer time and this prolonged their 
hospitalization time.6 
Pharmacokinetics of carbamazepine in 
children is age- and body weight- dependent 
and highly variable due to influence of dosing 
regimen and comedication.7 There is an 
association of variants of genes that regulate 
certain isoforms of cytochrome P450 enzymes 
(CYPs), some sodium channels, and drug 
transporters with either pharmacokinetics or 
pharmacodynamics of carbamazepine in 
children.8 Genetic factors contribute to the high 
interindividual variability in response to 
antiepileptic drugs (AEDs). However, most 
genetic markers identified to date have limited 
sensitivity and specificity, and the value of 
genetic testing in guiding AED therapy is 
limited.9 The use of genetic testing to guide 
epilepsy treatment is likely to increase in the 
future, as better understanding of the function 
of epilepsy genes will permit the application of 
precision medicine targeting the biological 
mechanisms responsible for epilepsy in the 
specific individual.10. 
Conclusion 
The results of this study showed that skin 
reactions were one of the most frequent side 
effects of carbamazepine. Given the 
importance of the adverse reactions to this 
medicine, the appearance of these 
complications and particularly, the initial 
symptoms including skin reactions, should be 
noteworthy to the doctors. The findings also 
point out to the poor drug compliance in 
some families. They interfered in the dosage 
and the proper use of the medicine; thus, they 
could not live up to their medical prescription 
and this resulted in misusing of the drug in 
some children. Families should be perfectly 
justified about the exact dosage and timing of 
the drug and should be asked about how they 
are using the medication every time a doctor 
visits them. The average duration between the 
beginning of using the drug and admission of 
patients to the hospital was 21 ± 16 days. 
According to this, we could possibly say that 
generally, families did not pay enough 
attention to the danger of adverse reactions to 
carbamazepine and delayed in taking their 
children to a pediatric neurology center. In 
this study, the most prevalent skin lesions 
seen in the patients were erythroderma and 
maculopapular eruptions. According to this, 
if someone introduces these two types of skin 
lesion to the families as the most common 
ones caused by carbamazepine, it would be 
helping them get their children admitted to a 
medical center in a better time. Also 
according to the relationship between the 
dosage of medications and the incidence rate 
of each type of these lesions, increasing the 
dosage could cause severe and more 
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